Koppel Adam

Koppel Adam is listed in filings as Director at Foghorn Therapeutics Inc.. This profile follows SEC Form 4 activity through Aug 5, 2024, including 5 public disclosures. Recent filings connect the profile to Foghorn Therapeutics Inc. (FHTX) and Cerevel Therapeutics Holdings, Inc. (CERE). The current snapshot covers public activity from Jun 28, 2024 to Aug 5, 2024. Reported amounts are shown as $88.3K to $147.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.